J. M. Goodrich

4.3k total citations · 3 hit papers
19 papers, 3.3k citations indexed

About

J. M. Goodrich is a scholar working on Epidemiology, Infectious Diseases and Hematology. According to data from OpenAlex, J. M. Goodrich has authored 19 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Hematology. Recurrent topics in J. M. Goodrich's work include Cytomegalovirus and herpesvirus research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Respiratory viral infections research (5 papers). J. M. Goodrich is often cited by papers focused on Cytomegalovirus and herpesvirus research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Respiratory viral infections research (5 papers). J. M. Goodrich collaborates with scholars based in United States, United Kingdom and Japan. J. M. Goodrich's co-authors include Philip D. Greenberg, Stanley R. Riddell, Mounzer Agha, Motomi Mori, Estella Whimbey, Nadeem Q. Mirza, Bernadette DeArmond, Curt A. Gleaves, Joel D. Meyers and William Buhles and has published in prestigious journals such as Science, New England Journal of Medicine and Annals of Internal Medicine.

In The Last Decade

J. M. Goodrich

19 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones

1992 1.0k citations Stanley R. Riddell, J. M. Goodrich et al. Science profile →
Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant

1993 514 citations J. M. Goodrich et al. Annals of Internal Medicine profile →
Early Treatment with Ganciclovir to Prevent Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation

1991 454 citations J. M. Goodrich, Motomi Mori et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. M. Goodrich United States	16	2.6k	1.0k	878	791	471	19	3.3k
J D Meyers United States	20	2.6k 1.0×	711 0.7×	853 1.0×	480 0.6×	694 1.5×	28	3.2k
Katherine N. Ward United Kingdom	34	3.1k 1.2×	1.6k 1.6×	1.3k 1.5×	321 0.4×	450 1.0×	66	4.4k
Curt A. Gleaves United States	19	2.1k 0.8×	752 0.7×	347 0.4×	259 0.3×	309 0.7×	48	2.5k
Patrice Morel France	35	1.3k 0.5×	483 0.5×	761 0.9×	515 0.7×	247 0.5×	123	3.3k
Hermann Einsele Germany	35	4.1k 1.6×	950 0.9×	1.3k 1.5×	1.1k 1.4×	915 1.9×	71	4.8k
Belinda Yen‐Lieberman United States	33	1.8k 0.7×	1.0k 1.0×	465 0.5×	413 0.5×	101 0.2×	118	3.4k
B Lönnqvist Sweden	36	1.4k 0.6×	391 0.4×	843 1.0×	729 0.9×	1.7k 3.7×	110	3.4k
E. Graham Davies United Kingdom	29	1.6k 0.6×	656 0.7×	821 0.9×	1.6k 2.0×	597 1.3×	71	4.4k
Catherine Scieux France	29	1.4k 0.5×	415 0.4×	538 0.6×	462 0.6×	424 0.9×	84	2.3k
Terry Stevens‐Ayers United States	26	2.0k 0.8×	782 0.8×	729 0.8×	568 0.7×	615 1.3×	57	2.8k

Countries citing papers authored by J. M. Goodrich

Since Specialization

Citations

This map shows the geographic impact of J. M. Goodrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. M. Goodrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. M. Goodrich more than expected).

Fields of papers citing papers by J. M. Goodrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. M. Goodrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. M. Goodrich. The network helps show where J. M. Goodrich may publish in the future.

Co-authorship network of co-authors of J. M. Goodrich

This figure shows the co-authorship network connecting the top 25 collaborators of J. M. Goodrich. A scholar is included among the top collaborators of J. M. Goodrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. M. Goodrich. J. M. Goodrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Fleishaker, Dona, Xin Wang, Sujatha Menon, et al.. (2012). Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial. Arthritis Research & Therapy. 14(1). R11–R11. 51 indexed citations

Nelson, Mark, Martin Fisher, Juan González‐García, et al.. (2010). Impact of Baseline Antiretroviral Resistance Status on Efficacy Outcomes Among Patients Receiving Maraviroc Plus Optimized Background Therapy in the MOTIVATE 1 and 2 Trials. HIV Clinical Trials. 11(3). 145–155. 1 indexed citations

Goldani, Luciano Zubaran, et al.. (2007). An Open-Label Comparative Pilot Study of Oral Voriconazole and Itraconazole for Long-Term Treatment of Paracoccidioidomycosis. Clinical Infectious Diseases. 45(11). 1462–1469. 72 indexed citations

Moyle, Graeme, Adrian Wildfire, Sundhiya Mandalia, et al.. (2005). Epidemiology and Predictive Factors for Chemokine Receptor Use in HIV‐1 Infection. The Journal of Infectious Diseases. 191(6). 866–872. 169 indexed citations

Zervos, Marcus, et al.. (2005). Novel, Single-Dose Microsphere Formulation of Azithromycin Versus Levofloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis. Infectious Diseases in Clinical Practice. 13(3). 115–121. 13 indexed citations

Li, C., J. M. Goodrich, & X. Jessie Yang. (1997). Interferon-gamma (IFN-γ) regulates production of IL-10 and IL-12 in human herpesvirus-6 (HHV-6)-infected monocyte/macrophage lineage. Clinical & Experimental Immunology. 109(3). 421–425. 27 indexed citations

Mera, Junichiro, Estella Whimbey, Linda S. Elting, et al.. (1996). Cytomegalovirus Pneumonia in Adult Nontransplantation Patients with Cancer: Review of 20 Cases Occurring from 1964 Through 1990. Clinical Infectious Diseases. 22(6). 1046–1050. 47 indexed citations

Whimbey, Estella, R. Champlin, R. B. Couch, et al.. (1996). Community Respiratory Virus Infections Among Hospitalized Adult Bone Marrow Transplant Recipients. Clinical Infectious Diseases. 22(5). 778–782. 252 indexed citations

Lewis, Victor, R. Champlin, J. A. Englund, et al.. (1996). Respiratory Disease Due to Parainfluenza Virus in Adult Bone Marrow Transplant Recipients. Clinical Infectious Diseases. 23(5). 1033–1037. 117 indexed citations

10.

Whimbey, Estella, R. B. Couch, Janet A. Englund, et al.. (1995). Respiratory Syncytial Virus Pneumonia in Hospitalized Adult Patients with Leukemia. Clinical Infectious Diseases. 21(2). 376–379. 100 indexed citations

11.

Whimbey, Estella, R. Champlin, J. A. Englund, et al.. (1995). Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.. PubMed. 16(3). 393–9. 167 indexed citations

12.

Goodrich, J. M., Michael Boeckh, & Raleigh A. Bowden. (1994). Strategies for the Prevention of Cytomegalovirus Disease After Marrow Transplantation. Clinical Infectious Diseases. 19(2). 287–298. 44 indexed citations

13.

Goodrich, J. M., et al.. (1993). Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant. Annals of Internal Medicine. 118(3). 173–178. 514 indexed citations breakdown →

14.

Riddell, Stanley R., et al.. (1992). Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones. Science. 257(5067). 238–241. 1010 indexed citations breakdown →

15.

Goodrich, J. M., Elizabeth Reed, Motomi Mori, et al.. (1991). Clinical Features and Analysis of Risk Factors for Invasive Candidal Infection after Marrow Transplantation. The Journal of Infectious Diseases. 164(4). 731–740. 170 indexed citations

16.

Goodrich, J. M., Motomi Mori, Curt A. Gleaves, et al.. (1991). Early Treatment with Ganciclovir to Prevent Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation. New England Journal of Medicine. 325(23). 1601–1607. 454 indexed citations breakdown →

17.

Greenberg, Philip D., P Reusser, J. M. Goodrich, & Stanley R. Riddell. (1991). Development of a Treatment Regimen for Human Cytomegalovirus (CMV) Infection in Bone Marrow Transplantation Recipients by Adoptive Transfer of Donor‐Derived CMV‐Specific T Cell Clones Expanded In Vitro^a. Annals of the New York Academy of Sciences. 636(1). 184–195. 61 indexed citations

18.

Edwards, Mark L., et al.. (1982). Infection with Mycobacterium avium-intracellulare and the Protective Effects of Bacille Calmette-Guerin. The Journal of Infectious Diseases. 145(5). 733–741. 59 indexed citations

19.

Goodrich, J. M., et al.. (1980). In vitro inhibition ofHerpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate. Archives of Virology. 66(3). 261–264. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact